Skip to main content
SpringerLink
Log in

Cannabinoids: Neurochemistry and neurobiology

  • Published:
Biology Bulletin Reviews Aims and scope Submit manuscript

Abstract

A large group of biologically active compounds that influence cannabinoid receptors—cannabinoids—is considered. The modern concepts of endocannabinoid neurotransmitter systems, their modulation, and biological role are described. Chemical classification of the ligands of cannabinoid receptors and the patterns of signal transduction in endocannabinoid systems are discussed. The leading role of neurochemical and neurobiological components contributing to cannabinoid dependence is substantiated. In addition, changes in endocannabinoid systems play an important role in the pathogenesis of other chemical dependences. Therefore, the modification of endocannabinoid systems with the help of various remedies is a promising trend in the prevention and treatment of both cannabinoid addiction and dependences on other psychoactive drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ashton, S., Narkologiya, 2009, no. 9, p. 71.

  2. Balashov, A.M., Narkologiya, 2004, no. 11, p. 5.

  3. Zanin, S.A. and Kade, A.Kh., Usp. Fiziol. Nauk, 2007, vol. 38, no. 1, p. 66.

    PubMed  CAS  Google Scholar 

  4. Zvartau, E.E., A Method for Investigation for Drug and Inhalant Abuse, in Itogi nauki i tekhniki. Ser. Narkologiya (Advances in Science and Technology, Ser. Addictology), Moscow: VINITI, 1988, vol. 1.

    Google Scholar 

  5. Kesel’man, L.E. and Matskevich, M.G., in Sotsial’noe prostranstvo narkotizma. Narkobiznes. Nachal’naya teoriya ekonomicheskoi otrasli (The Social Space of Narcotics Abuse. Drug Dealing. The Initial Theory of Economic Sectors), St. Petersburg: Meditsinskaya pressa, 2001, p. 8.

    Google Scholar 

  6. Koshkina, E.A. and Kirzhanova, V.V., Narkologiya, 2009, no. 8, p. 41.

  7. Postanovlenie Pravitel’stva Rossiiskoi Federatsii 1 681 ot 30 iyunya 1998 g. “Ob utverzhdenii perechnya narkoticheskikh sredstv, psikhotropnykh veshchestv i ikh prekursorov, podlezhashchikh kontrolyu v Rossiiskoi Federatsii” (v red. Postanovlenii Pravitel’stva RF ot 06.02.2004 51, ot 17.11.2004 648, ot 08.07.2006 421, ot 04.07.2007 427, ot 31.12.2009 1186 (Resolution of the Government of the Russian Federation No. 681 dated June 30, 1998, “On Approving the List of Narcotic Drugs, Psychotropic Substances, and Precursors Subject to Control in the Russian Federation” (in the edition of Resolutions of the Government of the Russian Federation No. 51 issued 06.02.2004, No. 648 issued 17.11.2004, No. 421 issued 08.07.2006, No. 427 issued 04.07.2007, and No. 1186 issued 31.12.2009).

  8. Churyukanov, M.V. and Churyukanov, V.V., Eksp Klin. Farmakol., 2004, vol. 67, no. 2, p. 70.

    CAS  Google Scholar 

  9. Shabanov, P.D., Lebedev, A.A., and Meshcherov, Sh.K., Dofamin i podkreplyayushchie sistemy mozga (Dopamine and Reinforcing Systems of the Brain), St. Petersburg: Lan’, 2002.

    Google Scholar 

  10. Arnold, J.C., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 396.

    PubMed  CAS  Google Scholar 

  11. Basavarajappa, B.S., Protein Pept. Lett., 2007, vol. 14, no. 3, p. 237.

    PubMed  CAS  Google Scholar 

  12. Bortolato, M., Campolongo, P., Mangieri, R.A., Scattoni, M.L., Frau, R., Trezza, V., La Rana, G., Russo, R., Calignano, A., Gessa, G.L., Cuomo, V., and Piomelli, D., Neuropsychopharmacology, 2006, vol. 31, no. 12, p. 2652.

    PubMed  CAS  Google Scholar 

  13. Braida, D., Pozzi, M., Cavallini, R., and Sala, M., Neuroscience, 2001, vol. 104, no. 4, p. 923.

    PubMed  CAS  Google Scholar 

  14. Caille, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D.G., and Parsons, L.H., J. Neurosci., 2007, vol. 27, no. 14, p. 3695.

    PubMed  CAS  Google Scholar 

  15. Carboni, E., Silvagni, A., Rolando, M.T., and Di Chiara, G., J. Neurosci., 2000, vol. 20, no. 20, p. RC102.

    PubMed  CAS  Google Scholar 

  16. Castane, A., Berrendero, F., and Maldonado, R., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 381.

    PubMed  CAS  Google Scholar 

  17. Castane, A., Valjent, E., Ledent, C., Parmentier, M., Maldonado, R., and Valverde, O., Neuropharmacology, 2002, vol. 43, no. 5, p. 857.

    PubMed  CAS  Google Scholar 

  18. Cheer, J.F., Wassum, K.M., Heien, M.L., Phillips, P.E., and Wightman, R.M., J. Neurosci., 2004, vol. 24, no. 18, p. 4393.

    PubMed  CAS  Google Scholar 

  19. Colombo, G., Serra, S., Vacca, G., Carai, M.A., and Gessa, G.L., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 369.

    PubMed  CAS  Google Scholar 

  20. Cooper, Z.D. and Haney, M., Addict. Biol., 2008, vol. 13, no. 2, p. 188.

    PubMed  CAS  Google Scholar 

  21. Cossu, G., Ledent, C., Fattore, L., Imperato, A., Bohme, G.A., Parmentier, M., and Fratta, W., Behav. Brain Res., 2001, vol. 118, no. 1, p. 61.

    PubMed  CAS  Google Scholar 

  22. Antona, A.M., Ahn, K.H., Wang, L., Mierke, D.F., Lucas-Lenard, J., and Kendall, D.A., Brain Res., 2006, vol. 1108, no. 1, p. 1.

    PubMed  Google Scholar 

  23. De Petrocellis, L., Cascio, M.G., and Di Marzo, V., Br. J. Pharmacol., 2004, vol. 141, no. 5, p. 765.

    PubMed  Google Scholar 

  24. De Vries, T.J. and Schoffelmeer, A.N., Trends Pharmacol. Sci., 2005, vol. 26, no. 8, p. 420.

    PubMed  Google Scholar 

  25. De Vries, T.J., Shaham, Y., Homberg, J.R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L.J., and Schoffelmeer, A.N., Nat. Med., 2001, vol. 7, no. 10, p. 1151.

    PubMed  Google Scholar 

  26. Devane, W.A., Dysarz, F.A., 3rd, Johnson, M.R., Melvin, L.S., and Howlett, A.C., Mol. Pharmacol., 1988, vol. 34, no. 5, p. 605.

    PubMed  CAS  Google Scholar 

  27. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffi, N.G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R., Science, 1992, vol. 258, no. 5090, p. 1946.

    PubMed  CAS  Google Scholar 

  28. Di Chiara, G. and Imperato, A., Proc. Natl. Acad. Sci. USA, 1988, vol. 85, no. 14, p. 5274.

    PubMed  Google Scholar 

  29. Erickson, C.K., Alcohol Alcohol., 1996, vol. 31, no. Suppl. 1, p. 5.

    PubMed  CAS  Google Scholar 

  30. Fattore, L., Cossu, G., Martellotta, C.M., and Fratta, W., Psychopharmacology (Berl.), 2001, vol. 156, no. 4, p. 410.

    CAS  Google Scholar 

  31. Fattore, L., Deiana, S., Spano, S.M., Cossu, G., Fadda, P., Scherma, M., and Fratta, W., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 343.

    PubMed  CAS  Google Scholar 

  32. Fattore, L., Spano, M.S., Deiana, S., Melis, V., Cossu, G., Fadda, P., and Fratta, W., Brain Res. Rev., 2007, vol. 53, no. 1, p. 1.

    PubMed  CAS  Google Scholar 

  33. French, E.D., Neurosci. Lett., 1997, vol. 226, no. 3, p. 159.

    PubMed  CAS  Google Scholar 

  34. French, E.D., Dillon, K., and Wu, X., Neuroreport, 1997, vol. 8, no. 3, p. 649.

    PubMed  CAS  Google Scholar 

  35. Gaoni, Y. and Mechoulam, R., J. Am. Chem. Soc., 1964, vol. 86, no. 8, p. 1646.

    CAS  Google Scholar 

  36. Gardner, E.L. and Lowinson, J.H., Pharmacol. Biochem. Behav., 1991, vol. 40, no. 3, p. 571.

    PubMed  CAS  Google Scholar 

  37. Gardner, E.L., Paredes, W., Smith, D., Donner, A., Milling, C., Cohen, D., and Morrison, D., Psychopharmacology (Berl.), 1988, vol. 96, no. 1, p. 142.

    CAS  Google Scholar 

  38. Gerdeman, G.L., Partridge, J.G., Lupica, C.R., and Lovinger, D.M., Trends Neurosci., 2003, vol. 26, no. 4, p. 184.

    PubMed  CAS  Google Scholar 

  39. Gianoulakis, C., Curr. Top. Med. Chem., 2009, vol. 9, no. 11, p. 999.

    PubMed  CAS  Google Scholar 

  40. Gold, L.H., Balster, R.L., Barrett, R.L., Britt, D.T., and Martin, B.R., J. Pharmacol. Exp. Ther., 1992, vol. 262, no. 2, p. 479.

    PubMed  CAS  Google Scholar 

  41. Herz, A., Can. J. Physiol. Pharmacol., 1998, vol. 76, no. 3, p. 252.

    PubMed  CAS  Google Scholar 

  42. Howlett, A.C., Barth, F., Bonner, T.I., Cabral, G., Casellas, P., Devane, W.A., Felder, C.C., Herkenham, M., Mackie, K., Martin, B.R., Mechoulam, R., and Pertwee, R.G., Pharmacol. Rev., 2002, vol. 54, no. 2, p. 161.

    PubMed  CAS  Google Scholar 

  43. Howlett, A.C., Mukhopadhyay, S., Shim, J.-Y., and Welsh, W.J., Life Sci., 1999, vol. 65, nos. 6–7, p. 617.

    PubMed  CAS  Google Scholar 

  44. Huffman, J.W. and Padgett, L.W., Curr. Med. Chem., 2005, vol. 12, no. 12, p. 1395.

    PubMed  CAS  Google Scholar 

  45. Huffman, J.W., Padgett, L.W., Isherwood, M.L., Wiley, J.L., and Martin, B.R., Bioorg. Med. Chem. Lett., 2006, vol. 16, no. 20, p. 5432.

    PubMed  CAS  Google Scholar 

  46. Huffman, J.W., Szklennik, P.V., Almond, A., Bushell, K., Selley, D.E., He, H., Cassidy, M.P., Wiley, J.L., and Martin, B.R., Bioorg. Med. Chem. Lett., 2005, vol. 15, no. 18, p. 4110.

    PubMed  CAS  Google Scholar 

  47. Huffman, J.W., Thompson, A.L., Wiley, J.L., and Martin, B.R., Bioorg. Med. Chem., 2008, vol. 16, no. 1, p. 322.

    PubMed  CAS  Google Scholar 

  48. Huffman, J.W., Zengin, G., Wu, M.J., Lu, J., Hynd, G., Bushell, K., Thompson, A.L., Bushell, S., Tartal, C., Hurst, D.P., Reggio, P.H., Selley, D.E., Cassidy, M.P., Wiley, J.L., and Martin, B.R., Bioorg. Med. Chem., 2005, vol. 13, no. 1, p. 89.

    PubMed  CAS  Google Scholar 

  49. Hungund, B.L. and Basavarajappa, B.S., Alcohol Alcohol., 2000, vol. 35, no. 2, p. 126.

    PubMed  CAS  Google Scholar 

  50. Ikemoto, S. and Panksepp, J., Brain Res. Rev., 1999, vol. 31, no. 1, p. 6.

    PubMed  CAS  Google Scholar 

  51. Jarbe, T.U., Lamb, R.J., Lin, S., and Makriyannis, A., Psychopharmacology (Berl.), 2001, vol. 156, no. 4, p. 369.

    CAS  Google Scholar 

  52. Jarbe, T.U., Li, C., Vadivel, S.K., and Makriyannis, A., Psychopharmacology (Berl.), 2010, vol. 208, no. 1, p. 87.

    Google Scholar 

  53. Jarbe, T.U., Liu, Q., and Makriyannis, A., Psychopharmacology (Berl.), 2006, vol. 184, no. 1, p. 36.

    Google Scholar 

  54. Justinova, Z., Goldberg, S.R., Heishman, S.J., and Tanda, G., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 285.

    PubMed  CAS  Google Scholar 

  55. Justinova, Z., Solinas, M., Tanda, G., Redhi, G.H., and Goldberg, S.R., J. Neurosci., 2005, vol. 25, no. 23, p. 5645.

    PubMed  CAS  Google Scholar 

  56. Justinova, Z., Tanda, G., Redhi, G.H., and Goldberg, S.R., Psychopharmacology (Berl.), 2003, vol. 169, no. 2, p. 135.

    CAS  Google Scholar 

  57. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., and Watanabe, M., Physiol. Rev., 2009, vol. 89, no. 1, p. 309.

    PubMed  CAS  Google Scholar 

  58. Kapur, A., Hurst, D.P., Fleischer, D., Whitnell, R., Thakur, G.A., Makriyannis, A., Reggio, P.H., and Abood, M.E., Mol. Pharmacol., 2007, vol. 71, no. 6, p. 1512.

    PubMed  CAS  Google Scholar 

  59. Kapur, A., Samaniego, P., Thakur, G.A., Makriyannis, A., and Abood, M.E., J. Pharmacol. Exp. Ther., 2008, vol. 325, no. 1, p. 341.

    PubMed  CAS  Google Scholar 

  60. Koob, G.F., Addiction, 2006, vol. 101, no. Suppl. 1, p. 23.

    PubMed  Google Scholar 

  61. Koob, G.F., Eur. Neuropsychopharmacol., 2003, vol. 13, no. 6, p. 442.

    PubMed  CAS  Google Scholar 

  62. Koob, G.F., Le Moal M, Science, 1997, vol. 278, no. 5335, p. 52.

    PubMed  CAS  Google Scholar 

  63. Le Foll, B. and Goldberg, S.R., J. Pharmacol. Exp. Ther., 2005, vol. 312, no. 3, p. 875.

    PubMed  Google Scholar 

  64. Lepore, M., Vorel, S.R., Lowinson, J., and Gardner, E.L., Life Sci., 1995, vol. 56, nos. 23–24, p. 2073.

    PubMed  CAS  Google Scholar 

  65. Lupica, C.R., Riegel, A.C., and Hoffman, A.F., Br. J. Pharmacol., 2004, vol. 143, no. 2, p. 227.

    PubMed  CAS  Google Scholar 

  66. Mansbach, R.S., Nicholson, K.L., Martin, B.R., and Balster, RL., Behav. Pharmacol., 1994, vol. 5, no. 2, p. 219.

    PubMed  CAS  Google Scholar 

  67. Martellotta, M.C., Cossu, G., Fattore, L., Gessa, G.L., and Fratta, W., Neuroscience, 1998, vol. 85, no. 2, p. 327.

    PubMed  CAS  Google Scholar 

  68. Martin, B.R., Mechoulam, R., and Razdan, R.K., Life Sci., 1999, vol. 65, nos. 6–7, p. 573.

    PubMed  CAS  Google Scholar 

  69. Martin, M., Ledent, C., Parmentier, M., Maldonado, R., and Valverde, O., Eur. J. Neurosci., 2000, vol. 12, no. 11, p. 4038.

    PubMed  CAS  Google Scholar 

  70. Mas-Nieto, M., Pommier, B., Tzavara, E.T., Caneparo, A., Da Nascimento, S., Le Fur, G., Roques, B.P., and Noble, F., Br. J. Pharmacol., 2001, vol. 132, NO. 8, p. 1809.

    PubMed  CAS  Google Scholar 

  71. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I., Nature, 1990, vol. 346, no. 6284, p. 561.

    PubMed  CAS  Google Scholar 

  72. McAllister, S.D., Hurst, D.P., Barnett-Norris, J., Lynch, D., Reggio, P.H., and Abood, M.E., J. Biol. Chem., 2004, vol. 279, no. 46, p. 48024.

    PubMed  CAS  Google Scholar 

  73. McMahon, L.R., J. Pharmacol. Exp. Ther., 2006, vol. 319, no. 3, p. 1211.

    PubMed  CAS  Google Scholar 

  74. McMahon, L.R., Amin, M.R., and France, C.P., Behav. Pharmacol., 2005, vol. 16, nos. 5–6, p. 363.

    PubMed  CAS  Google Scholar 

  75. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffi, N.G., Bayewitch, M., Barg, J., and Vogel, Z., Biochem. Pharmacol., 1995, vol. 50, no. 1, p. 83.

    PubMed  CAS  Google Scholar 

  76. Mechoulam, R. and Gaoni, Y., J. Am. Chem. Soc., 1965, vol. 87, p. 3273.

    PubMed  CAS  Google Scholar 

  77. Mechoulam, R., Hanus, L., and Martin, B.R., Biochem. Pharmacol., 1994, vol. 48, no. 8, p. 1537.

    PubMed  CAS  Google Scholar 

  78. Melis, M., Gessa, G.L., and Diana, M., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2000, vol. 24, no. 6, p. 993.

    PubMed  CAS  Google Scholar 

  79. Mendizabal, V., Zimmer, A., and Maldonado, R., Neuropsychopharmacology, 2006, vol. 31, no. 9, p. 1957.

    PubMed  CAS  Google Scholar 

  80. Munro, S., Thomas, K.L., and Abu-Shaar, M., Nature, 1993, vol. 365, no. 6441, p. 61.

    PubMed  CAS  Google Scholar 

  81. Naassila, M., Pierrefiche, O., Ledent, C., and Daoust, M., Neuropharmacology, 2004, vol. 46, no. 2, p. 243.

    PubMed  CAS  Google Scholar 

  82. Navarro, M., Carrera, M.R., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J.A., Gomez, R., del Arco, I., Villanua, M.A., Maldonado, R., Koob, G.F., and de Fonseca, F.R., J. Neurosci., 2001, vol. 21, no. 14, p. 5344.

    PubMed  CAS  Google Scholar 

  83. Pacher, P., Batkai, S., and Kunos, G., Pharmacol. Rev., 2006, vol. 58, no. 3, p. 389.

    PubMed  CAS  Google Scholar 

  84. Panagis, G., Vlachou, S., and Nomikos, G.G., Curr. Drug Abuse Rev., 2008, vol. 1, no. 3, p. 350.

    PubMed  CAS  Google Scholar 

  85. Parolaro, D., Massi, P., Rubino, T., and Monti, E., Prostaglandins Leukot. Essent. Fatty Acids, 2002, vol. 66, no. 2, p. 319.

    PubMed  CAS  Google Scholar 

  86. Pertwee, R.G., Life Sci., 1999, vol. 65, nos. 6–7, p. 597.

    PubMed  CAS  Google Scholar 

  87. Pontieri, F.E., Monnazzi, P., Scontrini, A., Buttarelli, F.R., and Patacchioli, F.R., Eur. J. Pharmacol., 2001, vol. 421, no. 3.

  88. Racz, I., Bilkei-Gorzo, A., Toth, Z.E., Michel, K., Palkovits, M., and Zimmer, A., J. Neurosci., 2003, vol. 23, no. 6, p. 2453.

    PubMed  CAS  Google Scholar 

  89. Rice, O.V., Gordon, N., and Gifford, A.N., Brain Res., 2002, vol. 945, no. 1, p. 135.

    PubMed  CAS  Google Scholar 

  90. Robinson, T.E. and Berridge, K.C., Brain Res. Rev., 1993, vol. 18, no. 3, p. 247.

    PubMed  CAS  Google Scholar 

  91. Robledo, P., Trigo, J.M., Panayi, F., de la Torre, R., and Maldonado, R., Psychopharmacology (Berl.), 2007, vol. 195, no. 2, p. 255.

    CAS  Google Scholar 

  92. Roche, J.P., Bounds, S., Brown, S., and Mackie, K., Mol. Pharmacol., 1999, vol. 56, no. 3, p. 611.

    PubMed  CAS  Google Scholar 

  93. Rodriguez de Fonseca, F., Del Arco, I., Bermudez-Silva, F.J., Bilbao, A., Cippitelli, A., and Navarro, M., Alcohol Alcohol., 2005, vol. 40, no. 1, p. 2.

    PubMed  CAS  Google Scholar 

  94. Ronco, A.M., Llanos, M., Tamayo, D., and Hirsch, S., Pharmacology, 2007, vol. 79, no. 1, p. 12.

    PubMed  CAS  Google Scholar 

  95. Sala, M. and Braida, D., Pharmacol. Biochem. Behav., 2005, vol. 81, no. 2, p. 407.

    PubMed  CAS  Google Scholar 

  96. Solinas, M., Justinova, Z., Goldberg, S.R., and Tanda, G., J. Neurochem., 2006, vol. 98, no. 2, p. 408.

    PubMed  CAS  Google Scholar 

  97. Solinas, M., Panlilio, L.V., Antoniou, K., Pappas, L.A., and Goldberg, S.R., J. Pharmacol. Exp. Ther., 2003, vol. 306, no. 1, p. 93.

    PubMed  CAS  Google Scholar 

  98. Solinas, M., Tanda, G., Justinova, Z., Wertheim, C.E., Yasar, S., Piomelli, D., Vadivel, S.K., Makriyannis, A., and Goldberg, S.R., J. Pharmacol. Exp. Ther., 2007, vol. 321, no. 1, p. 370.

    PubMed  CAS  Google Scholar 

  99. Solinas, M., Yasar, S., and Goldberg, S.R., Pharmacol. Res., 2007, vol. 56, no. 5, p. 393.

    PubMed  CAS  Google Scholar 

  100. Stark, P. and Dews, P.B., J. Pharmacol. Exp. Ther., 1980, vol. 214, no. 1, p. 124.

    PubMed  CAS  Google Scholar 

  101. Tanda, G., Munzar, P., and Goldberg, S.R., Nat. Neurosci., 2000, vol. 3, no. 11, p. 1073.

    PubMed  CAS  Google Scholar 

  102. Tanda, G., Pontieri, F.E., and Di Chiara, G., Science, 1997, vol. 276, no. 5321, p. 2048.

    PubMed  CAS  Google Scholar 

  103. Tao, Q. and Abood, M.E., J. Pharmacol. Exp. Ther., 1998, vol. 285, no. 2, p. 651.

    PubMed  CAS  Google Scholar 

  104. Turu, G. and Hunyady, L., J. Mol. Endocrinol., 2010, vol. 44, no. 2, p. 75.

    PubMed  CAS  Google Scholar 

  105. Valjent, E. and Maldonado, R., Psychopharmacology (Berl.), 2000, vol. 147, no. 4, p. 436.

    CAS  Google Scholar 

  106. Vann, R.E., Warner, J.A., Bushell, K., Huffman, J.W., Martin, B.R., and Wiley, J.L., Eur. J. Pharmacol., 2009, vol. 615, nos. 1–3, p. 102.

    PubMed  CAS  Google Scholar 

  107. Vigano, D., Grazia, Cascio M., Rubino, T., Fezza, F., Vaccani, A., Di Marzo, V., and Parolaro, D., Neuropsychopharmacology, 2003, vol. 28, no. 6, p. 1160.

    PubMed  CAS  Google Scholar 

  108. Vlachou, S., Nomikos, G.G., Stephens, D.N., and Panagis, G., Behav. Pharmacol., 2007, vol. 18, no. 4, p. 311.

    PubMed  CAS  Google Scholar 

  109. Wiley, J.L., Compton, D.R., Dai, D., Lainton, J.A., Phillips, M., Huffman, J.W., and Martin, B.R., J. Pharmacol. Exp. Ther., 1998, vol. 285, no. 3, p. 995.

    PubMed  CAS  Google Scholar 

  110. Wiley, J.L., Huffman, J.W., Balster, R.L., and Martin, B.R., Drug Alcohol Depend., 1995, vol. 40, no. 1, p. 81.

    PubMed  CAS  Google Scholar 

  111. Wiley, J.L. and Martin, B.R., Eur. J. Pharmacol., 2003, vol. 471, no. 3, p. 185.

    PubMed  CAS  Google Scholar 

  112. World Drug Report 2004. United Nations Office for Drug Control and Crime Prevention, Oxford: Oxford Univ. Press, 2004.

  113. World Drug Report 2008, United Nations Publication, 2008.

  114. Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S.R., and Wise, R.A., J. Neurosci., 2006, vol. 26, no. 18, p. 4901.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bekhterev Regional Medical Therapy and Diagnostics Center, St. Petersburg, Russia

    A. I. Golovko

Authors
  1. A. I. Golovko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. I. Golovko.

Additional information

Original Russian Text © A.I. Golovko, 2011, published in Uspekhi Sovremennoi Biologii, 2011, Vol. 131, No. 3, pp. 280–291.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Golovko, A.I. Cannabinoids: Neurochemistry and neurobiology. Biol Bull Rev 1, 526–535 (2011). https://doi.org/10.1134/S2079086411060028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S2079086411060028

Keywords

Search

Navigation